Patents/Inventors

Adel Moussa

Burlington, MAUS15 patents

13 Patents

US125514992026
Highly Active Compounds Against COVID-19
Atea Pharmaceuticals, Inc.
0 cites
US124586562025
Advantageous Anti-hcv Combination Therapy
Atea Pharmaceuticals, Inc.
0 cites
US123926192025
Vehicle Localization System and Method
Profound Positioning Inc.
0 cites
US122264292025
Highly Active Compounds Against COVID-19
Atea Pharmaceuticals, Inc.
0 cites
US121345882024
Crystalline Epinephrine Malonate Salt
Biothea Pharma, Inc.
0 cites
US120844732024
Β-d-2′-deoxy-2′-α-fluoro-2′-β-c-substituted-2-modified-n6-substituted Purine Nucleotides for HCV Treatment
Atea Pharmaceuticals, Inc.
0 cites
US120063402024
Nucleotide Hemi-sulfate Salt for the Treatment of Hepatitis C Virus
Atea Pharmaceuticals, Inc.
0 cites
US119750162024
2′-substituted-n 6 -substituted Purine Nucleotides for RNA Virus Treatment
Atea Pharmaceuticals, Inc.
0 cites
US118132782023
Highly Active Compounds Against COVID-19
Atea Pharmaceuticals, Inc.
0 cites
US117380382023
Highly Active Compounds Against COVID-19
Atea Pharmaceuticals, Inc.
0 cites
US117074802023
Highly Active Compounds Against COVID-19
Atea Pharmaceuticals, Inc.
0 cites
US116908602023
Treatment of HCV Infected Patients with Cirrhosis
Atea Pharmaceuticals, Inc.
0 cites
US116301192023
System and Method for Determining Airspeed
UTI Limited Partnership
0 cites